Session I: Generating Anti-Tumor Immunity 8–9:55 a.m. EST Credits: .75 CEs Available
|
8 a.m.
|
Introduction Yvonne Saenger, MD – Albert Einstein College of Medicine
|
Credits: 8:05 a.m. |
No CME credits available The Adaptive Immune Response Jonathan D. Powell, MD, PhD – Calico
|
8:35 a.m. |
Overview of Innate Immunity in Cancer Immunotherapy and Complexities of Macrophages Jennifer L. Guerriero, PhD – Brigham and Women's Hospital
|
Credits: 9:05 a.m. |
No CME credits available Role of Dendritic Cells in Cancer Niroshana Anandasabapathy, MD, PhD – Weill Cornell Medicine
|
9:35 a.m. |
Session I Panel Discussion Moderator: Yvonne Saenger, MD – Albert Einstein College of Medicine Panelists: Session I Speakers
|
9:55 a.m. |
Break
|
Session II: Approaches to Immunotherapy I 10:10 a.m.–Noon EST Credits: .75 CEs Available
|
10:10 a.m. |
Immune Checkpoint Blockade in Cancer Therapy: New Insights into Therapeutic Mechanisms James P. Allison, PhD – The University of Texas MD Anderson Cancer Center
|
Credits: 10:40 a.m. |
No CME credits available Myeloid Derived Suppressor cells: From the Biology to Therapy Dmitry I. Gabrilovich, MD, PhD – AstraZeneca
|
Credits: 11:10 a.m. |
No CME credits available Cancer Vaccines Howard L. Kaufman, MD, FACS – Amkyra Therapeutics/Massachusetts General Hospital
|
11:40 a.m. |
Session II Panel Discussion Moderator: Yvonne Saenger, MD – Albert Einstein College of Medicine Panelists: Session II Speakers
|
Noon |
Lunch |
Session III: Approaches to Immunotherapy II 1:30–3:25 p.m. EST Credits: 1.75 CEs Available
|
1:30 p.m. |
Introduction Jennifer L. Guerriero, PhD – Brigham and Women's Hospital
|
1:35 p.m. |
Updates on CAR T Cell Therapies Carl H. June, MD – University of Pennsylvania
|
2:05 p.m. |
Microbiome Thomas F. Gajewski, MD, PhD – University of Chicago
|
2:35 p.m. |
Metabolism in Cancer Immunology and Immunotherapy Greg M. Delgoffe, PhD – University of Pittsburgh
|
3:05 p.m. |
Session III Panel Discussion Moderator: Jennifer L. Guerriero, PhD – Brigham and Women's Hospital Panelists: Session III Speakers
|
3:25 p.m. |
Break |
Session IV: Clinical Practice of Immunotherapy 3:40–5:30 p.m. EST Credits: 1.75 CEs Available
|
3:40 p.m. |
Immune Biomarkers to Guide Clinical Care Yvonne Saenger, MD – Albert Einstein College of Medicine
|
4:10 p.m. |
Identification and Management of Immune Related Adverse Events Anna C. Pavlick, MD, MBA – Weill Cornell Medicine
|
4:40 p.m. |
What You Need for a Good TIME (Tumor Immune MicroEnvironment) James L. Gulley, MD, PhD, FACP – National Cancer Institute
|
5:10 p.m. |
Session IV Panel Discussion Moderator: Jennifer L. Guerriero, PhD – Brigham and Women's Hospital Panelists: Session IV Speakers
|
5:25 p.m. |
Closing Remarks Jennifer L. Guerriero, PhD – Brigham and Women's Hospital
|